Breaking News Headlines Today

News from MedShadow

All of today’s top news stories from MedShadow. Get the full analysis behind how media bias impacts breaking news.

Overall, we’ve indexed 18 stories from MedShadow over the past 3 months.

We’ve assigned a media bias rating of unknown to MedShadow. You can read more about our methodology here.

Is MedShadow credible or reliable? Our Factuality score answers both of those questions. When it comes to MedShadow, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about MedShadow

Where is MedShadow located?MedShadow's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top MedShadow News

Environment · Spain

INVESTIGATING GENERICS: The Trouble With Generic Vyvanse - MedShadow Foundation | Independent Health & Wellness Journalism

Open the article to view the coverage from MedShadow See the Story

United States · United States

FDA SIDE EFFECTS UPDATE: Kidney Risks Tied to Dehydration From GLP-1 Drugs - MedShadow Foundation | Independent Health & Wellness Journalism

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects of your medications. In this installment, we’re highlighting safety updates concerning these drugs: Byetta, Bydureon BCISE, Mounjaro, Saxenda, Soliqua 100/33, Trulicity, Victoza, and Xultophy 100/3.6. How to Read This Report This report is prepared using the most recent information posted in t…See the Story

Mental Health · United States

Can I Take Creatine with SSRIs? - MedShadow Foundation | Independent Health & Wellness Journalism

FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations - MedShadow Foundation | Independent Health & Wellness Journalism

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns affecting your prescriptions. In this installment, we’re highlighting a large recall for AvKARE eye drops and artificial tears products. This installment also highlights FDA warning letters for three clinical trials violations and a fertility center inspection site violatio…Product Recalls · San Diego See the Story

Blunted Before They Can Bloom: How Antidepressants Might Disrupt Sexual Development in Youth - MedShadow Foundation | Independent Health & Wellness Journalism

P. began taking Zoloft — an antidepressant known generically as sertraline — for school-related anxiety right at the cusp of puberty. “I’d started masturbating around that time and had a few muted orgasms,” she says. “But over the next couple of years, my access to sexual sensation faded away. No one ever mentioned that my pills might have that effect. And I wasn’t asking those kinds of questions. I just figured it was a flaw in myself.” It was…San Diego · San Diego Read Article

Spice-Medication Interactions: What Every Clinician Needs to Know

Cinnamon, turmeric, and ginger may interact with anticoagulants and chemotherapeutics, raising bleeding risk and reducing drug efficacy in high doses.Medical · United States See the Story

Business Groups Sue over Iowa's New Law Regulating Pharmacy Benefit Managers

78% Center coverage: 9 sources

A new lawsuit says Iowa's law regulating pharmacy benefit managers will increase costs and violates the First Amendment and federal law.Unions See the Story

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis - MedShadow Foundation | Independent Health & Wellness Journalism

Eight years ago, Lisa Salberg, now 56, received a heart transplant at Newark Beth Israel Medical Center in New Jersey after living with hypertrophic cardiomyopathy (a heart muscle disorder that reduces blood flow through the ventricles) since childhood. Post-procedure, she was prescribed tacrolimus, the main oral medication responsible for preventing the body from rejecting a new heart. After her 2017 surgery, she began taking a generic form of …Newark, New Jersey · Newark Read Article

FDA SIDE EFFECTS UPDATE: Gabapentin and Pregabalin Withdrawal Risks - MedShadow Foundation | Independent Health & Wellness Journalism

Stay informed with the latest FDA safety updates on gabapentinoids, including Gralise, Horizant, Lyrica, and Neurontin.United States · United States Read Article

FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities - In Compliance Magazine

The U.S. Food and Drug Administration (FDA) is stepping up its use of unannounced inspections at foreign manufacturing facilities that produce medicines and other medical products. The post FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities appeared first on In Compliance Magazine.United States · United States See the Story

RFK Jr. removes all members of CDC panel advising U.S. on vaccines

51% Center coverage: 173 sources

Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he is “retiring” all 17 members of a crucial government panel of vaccine advisors. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in an opinion piece in the Wall Street Journal on Monday. Robert F. Kennedy Jr. · United States See the Story

News from MedShadow

News from MedShadow

Information about MedShadow

Media Bias Ratings

Factuality

Ownership

Top MedShadow News

INVESTIGATING GENERICS: The Trouble With Generic Vyvanse - MedShadow Foundation | Independent Health & Wellness Journalism

FDA SIDE EFFECTS UPDATE: Kidney Risks Tied to Dehydration From GLP-1 Drugs - MedShadow Foundation | Independent Health & Wellness Journalism

Can I Take Creatine with SSRIs? - MedShadow Foundation | Independent Health & Wellness Journalism

FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations - MedShadow Foundation | Independent Health & Wellness Journalism

Blunted Before They Can Bloom: How Antidepressants Might Disrupt Sexual Development in Youth - MedShadow Foundation | Independent Health & Wellness Journalism

Spice-Medication Interactions: What Every Clinician Needs to Know

Business Groups Sue over Iowa's New Law Regulating Pharmacy Benefit Managers

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis - MedShadow Foundation | Independent Health & Wellness Journalism

FDA SIDE EFFECTS UPDATE: Gabapentin and Pregabalin Withdrawal Risks - MedShadow Foundation | Independent Health & Wellness Journalism

FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities - In Compliance Magazine

RFK Jr. removes all members of CDC panel advising U.S. on vaccines

Similar News Topics

Topics Most Covered by MedShadow

Sources Covering Similar Topics

Breaking News Topics Related to MedShadow

Information about MedShadow

Media Bias Ratings

Factuality

Ownership

FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations - MedShadow Foundation | Independent Health & Wellness Journalism

Blunted Before They Can Bloom: How Antidepressants Might Disrupt Sexual Development in Youth - MedShadow Foundation | Independent Health & Wellness Journalism

Spice-Medication Interactions: What Every Clinician Needs to Know

Business Groups Sue over Iowa's New Law Regulating Pharmacy Benefit Managers

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis - MedShadow Foundation | Independent Health & Wellness Journalism

FDA SIDE EFFECTS UPDATE: Gabapentin and Pregabalin Withdrawal Risks - MedShadow Foundation | Independent Health & Wellness Journalism

FDA Expands Unannounced Inspections of Foreign Manufacturing Facilities - In Compliance Magazine

RFK Jr. removes all members of CDC panel advising U.S. on vaccines